Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo

July 2nd, 2008 by admin

Despite past advancement in its treatment, binary myeloma (MM) relic incurable, thusly necessitating finding of new anti-MM agents. We inform that the marine-derived cyclodepsipeptide Aplidin exhibits, at clinically realizable concentrations, multipotent in vitro state against direct MM growth cells and a panoptic spectrum of manlike MM radiophone lines, including cells nonabsorptive to customary (e.g., dexamethasone, alkylating agents, and anthracyclines) or new (e.g., thalidomide and bortezomib) anti-MM agents. Aplidin is astir against MM cells in the proximity of proliferative/antiapoptotic cytokines or pearl goody stromal cells and has cumulative or cooperative personalty with whatever of the ingrained anti-MM agents. Mechanistically, a brief in vitro danger to Aplidin induces MM radiophone death, which involves activation of p38 and c-jun NH2-terminal kinase signaling, Fas/CD95 translocation to glyceride rafts, and caspase activation. The anti-MM gist of Aplidin is related with quelling of a plan of proliferative/antiapoptotic genes (e.g., MYC, MYBL2, BUB1, MCM2, MCM4, MCM5, and survivin) and up-regulation of individual possibleness regulators of necrobiosis (including c-JUN, TRAIL, CASP9, and Smac). Aplidin exhibited in vivo anti-MM state in a pussyfoot transplant model. The strikingness of the anti-MM state of Aplidin in our diagnosing models provided the support for its clinical investigating in MM, which has already provided approbatory origin results. [Cancer Res 2008;68(13):5216–25] (Source: person Research)

 

MedWorm Sponsored Message: Find discover how you crapper get your communication crossways here by sponsoring this MedWorm programme feed.

Tags: , , , , , ,

Posted in Cancer |

Related posts

Comments are closed.